NIH director discusses the $1,000 genome, basic science

02/16/2012 | Medscape (free registration)

Advances in genome sequencing, genomic editing and induced pluripotent stem cells will revolutionize the practice of medicine, NIH Director Francis Collins says in this in-depth interview. For example, iPS cells could be used not only to study a particular patient's disease but also to develop personalized treatments, he says. Basic science supported by the NIH will help scientists develop algorithms to analyze complicated DNA and RNA sequences and translate the information into therapies, he says.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA